ArticleCancers2024

Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.

Gilles Houvenaeghel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.